News
CLVRW
0.0065
-80.06%
-0.0261
BUZZ-U.S. STOCKS ON THE MOVE-Fulton, Deciphera Pharmaceuticals, VivoPower
U.S. Stocks were poised for a higher open on Monday. Tesla and Apple led gains in megacap companies. Investors exercised caution ahead of the Federal Reserve's interest rate decision later in the week. Dow e-minis were up 0.14% in early trading.
Reuters · 22h ago
BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Apple, Domino's
U.S. Stock index futures edged higher on Monday. Tesla and Apple led gains in megacap companies. Investors exercise caution ahead of the Federal Reserve's interest rate decision later in the week. Dow e-minis were up 0.17% in early trading.
Reuters · 23h ago
Weekly Report: what happened at CLVRW last week (0422-0426)?
Weekly Report · 1d ago
Weekly Report: what happened at CLVRW last week (0415-0419)?
Weekly Report · 04/22 11:20
CLEVER LEAVES HOLDINGS- ON APRIL 16, PROVIDED NOTICE TO CANACCORD GENUITY LLC TO TERMINATE CERTAIN EQUITY DISTRIBUTION AGREEMENT, DATED JAN 14, 2022
Reuters · 04/17 20:49
Weekly Report: what happened at CLVRW last week (0408-0412)?
Weekly Report · 04/15 11:11
Weekly Report: what happened at CLVRW last week (0401-0405)?
Weekly Report · 04/08 11:17
Cannabis Company Clever Leaves Reports Q4 And 2023 Results: Revenue Growth And Expense Reductions
Clever Leaves Holdings Inc. Reported its financial results for the fourth quarter and full year of 2023. The company reported a 6% increase in revenue compared to the previous year, driven by a 39% rise in full-year cannabinoid revenue. Clever Leaves will host the Benzinga Cannabis Capital Conference in Florida in 2024.
Benzinga · 04/02 01:24
CLEVER LEAVES HOLDINGS INC - REVENUE IN Q4 OF 2023 INCREASED 5% TO $4.6 MLN
Reuters · 04/01 20:01
Weekly Report: what happened at CLVRW last week (0325-0329)?
Weekly Report · 04/01 11:14
Weekly Report: what happened at CLVRW last week (0318-0322)?
Weekly Report · 03/25 11:17
Weekly Report: what happened at CLVRW last week (0311-0315)?
Weekly Report · 03/18 11:16
Weed Giants Tilray And Curaleaf Ramp Up Presence In Europe, Here's Why
The European cannabis market is one of the most rapidly expanding markets globally. The combined market size of all CBD categories surpassed €2 billion in 2023. Germany, Czech Republic, Switzerland and the Netherlands are "early adopters" of the recreational cannabis market. The European market will be a hot topic at Benzinga's spring cannabis conference.
Benzinga · 03/14 14:57
Weekly Report: what happened at CLVRW last week (0304-0308)?
Weekly Report · 03/11 11:12
Weekly Report: what happened at CLVRW last week (0226-0301)?
Weekly Report · 03/04 11:15
Weekly Report: what happened at CLVRW last week (0219-0223)?
Weekly Report · 02/26 11:29
Weekly Report: what happened at CLVRW last week (0212-0216)?
Weekly Report · 02/19 11:30
Can Cannabis Treat Severe Forms Of Epilepsy? New Medicine Sparks Hope As Colombia's Weed Industry Goes Global
Clever Leaves Holdings Inc. Announced a strategic partnership with the renowned Dutch seed bank, Paradise Seeds to develop and register high-performance cannabis cultivars in Colombia. The Colombian Congress shelved a bill aimed at regulating adult use and commercialization of cannabis. Avicanna has achieved the first indication-specific drug registration for Trunerox. The developments in Colombia's cannabis industry have implications for companies operating in the country.
Benzinga · 02/14 16:21
Weekly Report: what happened at CLVRW last week (0205-0209)?
Weekly Report · 02/12 11:20
Weekly Report: what happened at CLVRW last week (0129-0202)?
Weekly Report · 02/05 11:28
More
Webull provides a variety of real-time CLVRW stock news. You can receive the latest news about Clever Leaves Holdings Inc through multiple platforms. This information may help you make smarter investment decisions.
About CLVRW
Clever Leaves Holdings Inc. is a multinational operator and licensed producer of pharmaceutical-grade cannabinoids. The Company's segments include Cannabinoid and Non-Cannabinoid. The Cannabinoid segment is comprised of cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products. The Non-Cannabinoid operating segment is comprised of the brands and manufacturing assets acquired as part of its acquisition of Herbal Brands. The Non-Cannabinoid segment is engaged in the business of formulating, manufacturing, marketing, selling, distributing, and otherwise commercializing wellness products and nutraceuticals, excluding cannabinoid products. Its customers for the Herbal Brands products include specialty and health retailers, mass retailers and specialty and health stores in the United States. It offers product portfolio in two categories: nutraceuticals and cannabinoids. The nutraceutical products consist of a variety of beverage and powder products.